Robert E. Shapiro

Robert E. Shapiro

Auto-generated profile, based on publicly available information

Robert E. Shapiro

Department of Neurological Sciences, Larner College of Medicine University of Vermont Burlington Vermont USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2024 in Neurology
Verified
Journal Article
Open access
RSRobert E. Shapiro
Robert E. Shapiro
RNRobert A. Nicholson
Robert A. Nicholson
ESElizabeth K. Seng
Elizabeth K. Seng
DBDawn C. Buse
Dawn C. Buse
MRMichael L. Reed
Michael L. Reed
RLRichard B. Lipton
Richard B. Lipton
This population-based analysis characterizes the relative frequency of migraine-related stigma and its cross-sectional relationship to migraine outcomes. We hypothesized that migraine-related stigma would be inversely associated with favorable migraine outcomes across headache day categories. OVERCOME (US) is a web-based observational study that annually recruited a demographically representative US sample and then identified people with active migraine using a validated migraine diagnostic questionnaire. It also assessed how frequently respondents experienced migraine-related stigma using a novel 12-item questionnaire (Migraine-Related Stigma, MiRS) that contained 2 factors; feeling that others viewed migraine as being used for Secondary Gain (8 items, α = 0.92) and feeling that others were Minimizing disease Burden (4 items, α = 0.86). We defined 5 groups: (1) MiRS-Both (Secondary Gain and Minimizing Burden often/very often; (2) MiRS-SG (Secondary Gain often/very often); (3) MiRS-MB (Minimizing Burden often/very often); (4) MiRS-Rarely/Sometimes; (5) MiRS-Never. Using MiRS group as the independent variable, we modeled its cross-sectional relationship to disability (Migraine Disability Assessment, MIDAS), interictal burden (Migraine Interictal Burden Scale-4), and migraine-specific quality of life (Migraine Specific Quality of Life v2.1 Role Function-Restrictive) while controlling for sociodemographics, clinical features, and monthly headache day categories. Among this population-based sample with active migraine (n = 59,001), mean age was 41.3 years and respondents predominantly identified as female (74.9%) and as White (70.1%). Among respondents, 41.1% reported experiencing, on average, ≥4 monthly headache days and 31.7% experienced migraine-related stigma often/very often; the proportion experiencing migraine-related stigma often/very often increased from 25.5% among those with <4 monthly headache days to 47.5% among those with ≥15 monthly headache days. The risk for increased disability (MIDAS score) was significant for each MiRS group compared with the MiRS-Never group; the risk more than doubled for the MiRS-Both group (rate ratio 2.68, 95% CI 2.56-2.80). For disability, interictal burden, and migraine-specific quality of life, increased migraine-related stigma was associated with increased disease burden across all monthly headache day categories. OVERCOME (US) found that 31.7% of people with migraine experienced migraine-related stigma often/very often and was associated with more disability, greater interictal burden, and reduced quality of life.

1 August 2008 in Current Pain and Headache Reports
Verified
Journal Article
Closed access
PDF file
RSRobert E. Shapiro
Robert E. Shapiro

1 May 2007 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
RSR. E. Shapiro
R. E. Shapiro

1 September 2010 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
SHSarah Hale
Sarah Hale
MCMartha Choate
Martha Choate
ASAdrienne Schonberg
Adrienne Schonberg
RSRobert Shapiro
Robert Shapiro
GBGary Badger
Gary Badger
IBIra M. Bernstein
Ira M. Bernstein

19 August 2020 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Open access
PDF file
RSRobert E. Shapiro
Robert E. Shapiro
Discrimination toward people living with migraine and other headache disorders is widespread and socially accepted. Stigma toward these diseases is both a manifestation of these discriminatory attitudes and a sustainer of them. For those living with migraine and headache disorders, stigma limits the full expression of their lives, as well as the likelihood of receiving health care to reduce the burden. In the past decade, public advocacy organizations have emerged in the United States and internationally to counter the consequences of this stigma. These organizations have raised public awareness of these diseases, corrected misconceptions, and empowered millions of people affected by them. The Alliance for Headache Disorders Advocacy has focused on addressing the structural stigma inherent in discriminatory policies of employers, government agencies, and public institutions. While notable progress has been made, there is considerable work left to be done to increase resources and equity for people living with headache disorders.

13 April 2007 in Current Pain and Headache Reports
Verified
Journal Article
Closed access
PDF file
AAAngela M. Applebee
Angela M. Applebee
RSRobert E. Shapiro
Robert E. Shapiro